$23 Bn Cell-based Assay Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

DUBLIN, July 15, 2019 /PRNewswire/ -- The "Cell-based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global cell-based assay market reached a value of US$ 14 Billion in 2018

The market is currently being catalysed by a number of factors, this includes rising investments in research and development, adoption of high throughput screening methods, increasing prevalence of various chronic diseases, growth in drug discovery activities, and the various advantages that cell-based assays offer over alternative technologies.

Cell-based assays refer to any experiment that use live cells. The basic techniques include a variety of assays that can be used for the purpose of measuring cell toxicity, proliferation, motility as well as production of a particular cellular product and cellular morphology. Cell-based assays provide a closer representation of the real life model since it employs live cells during experimentation. Cell-based assays have grown to become a versatile tool in healthcare research and development, particularly in the experiments which are designed to understand functionalities of specific cells like antibodies or drug efficacy on a group of cells.

There has been a significant increase in R&D funding by various public and private organisations so as to develop better and safer drugs. Moreover, technological advancements in cell-based assays have enabled researchers to start using this technology for drug discovery and toxicology studies.

Another major factor catalysing the growth of the market is the rising prevalence of lifestyle diseases such as arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc. which still have large unmet needs and have led to continuous investments in R&D. In addition, an increase in the adoption of the cell-based assay techniques for high throughput screening methods like toxicity studies, drug screening, in vitro testing, etc. are further driving this market.

The market value is further expected to reach more than US$ 23 Billion by 2024, exhibiting a CAGR of 8.6% during 2019-2024.

Market Summary:

Based on the product type, the market has been segmented as consumables, instruments, services and software. Currently, the consumables segment dominates the market, holding the largest share.

Based on the technology, the market has been segmented as automated handling, flow cytometry, label-free-detection, high-throughput screening, and others.

Based on the application, the market has been segmented as drug discovery, basic research, ADME studies, predictive toxicology and others. Currently, the drug discovery segment dominates the market, holding the largest share.

On the basis of end-user, the market has been segmented as pharmaceutical and biotechnology companies; academic and government institutions; contract research organizations; and others.

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Amongst these, North America is the leading market, accounting for the majority of the market share.

Companies Mentioned

• Becton Dickinson
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• General Electric Company
• Merck Group
• PerkinElmer
• Charles River Laboratories Inc.
• Lonza Group Ltd.
• Cell Signaling Technology
• Promega Corporation
• Cisbio Bioassays
• Cell Biolabs Inc.
• Discoverx Corporation
• Bio-Rad Laboratories Inc.
• Corning Inc.
• Hoffmann-La Roche Ltd

For more information about this report visit https://www.researchandmarkets.com/r/i8l8ej

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/23-bn-cell-based-assay-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024-300884918.html

SOURCE Research and Markets